New York Life Trust’s Chemours CC Stock Holding History

New York Life Trust’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$9K	Buy	+225	New	+$6.77K	0.44%	59

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

New York Life Trust's CC Position: Q1 2017 in Review

New York Life Trust opened a new position in Chemours (CC) in Q1 2017: 225 shares worth $9K. The stake represents 0.44% of the portfolio and ranks #59 among its holdings.

459 funds tracked by Wall St. Rank hold CC as of Q1 2017.

New York Life Trust held 225 shares of Chemours worth $9K as of Q1 2017.
Chemours was a new New York Life Trust position in Q1 2017.
Chemours made up 0.44% of New York Life Trust's portfolio in Q1 2017, its #59 holding.
459 funds tracked by Wall St. Rank held Chemours as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.